vTv Therapeutics
vTv Therapeutics develops oral, small molecule drug candidates for diabetes and chronic diseases.
10-K/AAug 14Latest SEC filing, period to Dec 31
Aug 6Latest story
August 2026
Sign inSign invTv Therapeutics develops oral, small molecule drug candidates for diabetes and chronic diseases.